Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
34.3M
-
Shares change
-
+3.57M
-
Total reported value, excl. options
-
$345M
-
Value change
-
+$34.2M
-
Put/Call ratio
-
1.13
-
Number of buys
-
61
-
Number of sells
-
-32
-
Price
-
$10.05
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q2 2017
120 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q2 2017.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.3M shares
of 157M outstanding shares and own 21.83% of the company stock.
Largest 10 shareholders include FMR LLC (6.45M shares), BRIDGER MANAGEMENT, LLC (4.65M shares), BlackRock Inc. (3.2M shares), STATE STREET CORP (2.64M shares), FRANKLIN RESOURCES INC (2.34M shares), VANGUARD GROUP INC (2.05M shares), COLUMBUS CIRCLE INVESTORS (1.4M shares), JENNISON ASSOCIATES LLC (1.35M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.11M shares), and SENZAR ASSET MANAGEMENT, LLC (969K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.